NCT00126061View on ClinicalTrials.gov

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Atrial FibrillationAtrial Flutter

Interventions

DRUG

Tedisamil sesquifumarate

Trial Locations (26)

Unknown

Site 26, Los Angeles

Site 27, Santa Ana

Site 24, Honolulu

Site 25, Tullahoma

Site 5, Brno

Site 4, Pilsen

Site 2, Prague

Site 3, Prague

Site 6, Prague

Site 8, Bydgoszcz

Site 11, Lodz

Site 10, Lublin

Site 12, Medyczna

Site 7, Warsaw

Site 9, Warsaw

Site 13, Moscow

Site 14, Moscow

Site 15, Moscow

Site 16, Moscow

Site 17, Moscow

Site 20, Dnipro

Site 18, Kiev

Site 21, Kiev

Site 19, Lviv

Site 23, Odesa

Site 22, Zaporizhzhya

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00126061 - Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects | Biotech Hunter | Biotech Hunter